Clinical Trials Logo

Ischemia Reperfusion Injury clinical trials

View clinical trials related to Ischemia Reperfusion Injury.

Filter by:

NCT ID: NCT03318575 Recruiting - Clinical trials for Ischemia-Reperfusion Injury

Remote Ischemic Conditioning Using the autoRIC

SHIELD
Start date: January 30, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the hypothesis that patients receiving remote ischemic conditioning using the autoRIC device show statistically significant reduction in the prevalence of ischemia-reperfusion injury to the myocardium as compared to patients in the autoRIC Sham device arm (within 12-24 hours post non-emergent PCI with stent implantation).

NCT ID: NCT02845154 Recruiting - Hypotension Clinical Trials

Intermittent Portal and Graft Purge in Living Donor Liver Transplantation

IPLDLT
Start date: October 2015
Phase: N/A
Study type: Interventional

Post-reperfusion syndrome and ischemia-reperfusion insult are a common well-known complication in liver transplantation. Several trials investigated variables that my contribute to the generation of these two complications for reducing their incidence and magnitude. The investigators will investigate the effect of acute conditioning of the recipients circulation to the vasoactive mediators in the graft as well as the congested intestine through intermittent purging of graft contents into the patient's systemic circulation in living donor liver transplantation.

NCT ID: NCT00534924 Recruiting - Clinical trials for Ischemia Reperfusion Injury

The Effects of Post-Conditioning and Administration of Vitamin C on Intramuscular High Energy Phosphate Levels

IRI in MRI
Start date: August 2007
Phase: N/A
Study type: Interventional

Ischemic injury to muscular tissue is common in cardiovascular medicine. The most effective treatment to avoid ischemic damage is the rapid re-establishment of reperfusion. However, reperfusion itself can result in additional damage to ischemic tissue. This phenomenon is called ischemia - reperfusion (IR) injury and is caused by different pathologic mechanisms. Therapies are required which can be administered after the onset of an ischemic event to protect the tissue against IR injury. Therefore, a promising strategy to reduce IR injury is post-conditioning. Likewise, pharmacological therapies administered after the onset of reperfusion might prevent tissue injury. We have recently shown that high concentrations of exogenous vitamin C abrogate experimental IR injury of the forearm vasculature in patients with peripheral artery disease and in healthy subjects. Study hypothesis We hypothesize that the administration of mechanical post-conditioning or of high-dose vitamin C may protect skeletal muscle against IR injury. This shall be studied employing MR spectroscopy of the leg, which is an established model to assess muscle aerobic energy metabolism. Design Three periods, three way cross over study in 10 volunteers. One screening visit, three one-day study days with two washout periods of >3 days in between are scheduled for each participant. The order of experimental days will be randomized. After the last treatment a final follow-up examination will be performed within one week.

NCT ID: NCT00526695 Recruiting - Clinical trials for Ischemia/Reperfusion Injury

Effects of Sevoflurane in Subanesthetic Concentrations on the Forearm Perfusion

Start date: January 2005
Phase: Phase 4
Study type: Interventional

Sevoflurane preconditioning and cardiovascular protection against ischemia/reperfusion injury. Study hypothesis: The volatile anesthetic sevoflurane at subanesthetic concentrations achieves endothelial protection against ischemia/reperfusion injury and reduces inflammatory markers in the circulation